3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
2
Lung Neoplasms
1
Carcinoma, Small Cell
1
Interventions
Topotecan
3
pembrolizumab
2
Gemcitabine
2
vinflunine
1
bemiparin
1
belotecan
1
apalutamide
1
Temozolomide
1
Taxes
1
Sorafenib
1
Penfluridol
1
Pemetrexed
1
Paclitaxel
1
Nortriptyline
1
Nivolumab
1
Ipilimumab
1
Etoposide
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Arsenic Trioxide
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Small Cell
×
belotecan
×
Clear all
NCT00826644
2021-08-09
COMBAT
Chonnam National University Hospital
Phase 3
Completed
147 enrolled